<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01885481</url>
  </required_header>
  <id_info>
    <org_study_id>B-1304-199-001</org_study_id>
    <nct_id>NCT01885481</nct_id>
  </id_info>
  <brief_title>Evaluation of Efficacy and Safety of Epidural Steroid Injection Using Dexamethasone or Betamethasone</brief_title>
  <official_title>Evaluation of Efficacy and Safety of Epidural Steroid Injection Using Dexamethasone or Betamethasone in Patients With Spinal Pain: a Prospective, Randomized, Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Particle steroid drug such as triamcinolone has been used widely for epidural steroid
      injection (ESI) treatment in Korea. However, Korea FDA recently prohibit ESI using
      triamcinolone, following the regulation of US FDA. Therefore, dexamethasone and betamethasone
      become only candidate drugs for ESI in Korea and the investigators are curious about the
      effectiveness and safety of both drugs due to limitation of information about comparison of
      two drugs in previous literature. So, this study aims to compare the effectiveness and safety
      of both drugs and our hypothesis is that there is no difference of the effectiveness between
      dexamethasone and betamethasone at 2 weeks after ESI.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the proportion of patients with pain improvement</measure>
    <time_frame>baseline and 2 weeks</time_frame>
    <description>the proportion of patients with significant pain improvement at 2 week after epidural steroid injection, with the patients' subjective satisfaction scale of &quot;much improved&quot; or &quot;no pain&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of adverse events</measure>
    <time_frame>during 12 weeks after epidural steroid injection</time_frame>
    <description>incidence of adverse event during 12 weeks after epidural steroid injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain relief</measure>
    <time_frame>baseline and 2 weeks</time_frame>
    <description>decrease of visual analog scale (VAS) for pain at 2 week time point after epidural steroid injection, compared to baseline at 0 week</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>disability improvement</measure>
    <time_frame>baseline and 2 weeks</time_frame>
    <description>decrease of disability index (Oswestry disability index or Neck disability index) for pain at 2 week time point after epidural steroid injection, compared to baseline at 0 week</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">600</enrollment>
  <condition>Back Pain</condition>
  <condition>Neck Pain</condition>
  <arm_group>
    <arm_group_label>ESI-1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>epidural steroid injection using dexamethasone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ESI-2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>epidural steroid injection using betamethasone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>epidural steroid injection using dexamethasone</description>
    <arm_group_label>ESI-1</arm_group_label>
    <other_name>dexamethasone-ESI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Betamethasone</intervention_name>
    <description>epidural steroid injection using betamethasone</description>
    <arm_group_label>ESI-2</arm_group_label>
    <other_name>betamethasone-ESI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. patients with spinal pain (i.e.neck pain, back pain, or radiculopathy..)

          2. patients with informed consent

          3. visual analog scale (VAS) is five or more in 10-point scale at screening

          4. sustained spinal pain, regardless of sufficient conservative treatment (i.e. oral
             medicine, physical therapy..)

        Exclusion Criteria:

          1. age of patient less than 19 years

          2. relative contraindication of epidural steroid injection, as follows:

               -  pregnant or breast-feeding state

               -  uncontrolled coagulopathy

               -  suspected of active infection state

               -  uncontrolled diabetes mellitus

               -  previous history of adverse event related to epidural steroid injection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joon Woo Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>763-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2013</study_first_submitted>
  <study_first_submitted_qc>June 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2013</study_first_posted>
  <last_update_submitted>March 28, 2016</last_update_submitted>
  <last_update_submitted_qc>March 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Joon Woo Lee</investigator_full_name>
    <investigator_title>Associate professor, Department of Radiology</investigator_title>
  </responsible_party>
  <keyword>dexamethasone</keyword>
  <keyword>betamethasone</keyword>
  <keyword>epidural steroid injection</keyword>
  <keyword>comparative effectiveness research</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Neck Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Betamethasone benzoate</mesh_term>
    <mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Betamethasone</mesh_term>
    <mesh_term>Betamethasone Valerate</mesh_term>
    <mesh_term>Betamethasone sodium phosphate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

